Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Enhancing Financial Value through Operational Excellence | Seth Brody, Partner, APAX Partners.
00:10:00
Metropolitan Commercial Bank: A Leader in Global Payments and Fintech Integration
00:10:00
Our President and CEO highlights three key focus areas driving DXC Technology's unique value and business growth.|Raul Fernandez is president and chief executive officer of DXC Technology
00:00:00
Patrys CEO & MD, Dr James Campbell
00:10:00
Value Creation Capital is a private equity firm specializing in growth companies|Willem van den Berg,Managing Partner,Value Creation Capital
00:10:00
David Berlinski on Scientific Overreach and the Myth of Global Warming
00:10:00
KSN Mining Unveils $100 Million Workshop Investment in Augusta
00:10:00
Technology's Impact on Education: Transforming Learning and Resisting Change|Terry M. Moe
00:10:00
A Discussion on an Industrial Plan's Impact on Energy Transition and Community Development | Stefano Cetti , CEO, Acinque SpA.
00:10:00
Invests in seed to growth stage startups that uses tech to disrupt existing markets or create entirely new ones|Aaref Hilaly,Partner,Bain Capital Ventures
00:10:00
Blue Bonds: Unlocking the Blue Economy's Potential - Insights from Matt Lawton and Tongai Kunorubwe at T. Rowe Price
00:10:00
Focuses on early-stage venture investing in mobile marketplaces social infrastructure and enterprise software.|Bob Kagle,General Partner,Benchmark

© 2026 Nehu